Skip to main content
Premium Trial:

Request an Annual Quote

GlaxoSmithKline Will Use Fluidigm s Microfluidic Chips

NEW YORK, Feb. 14 - Fluidigm Corporation will provide microfluidic platform technology, tools, software and customized microfluidic prototype chips for GlaxoSmithKline, the company said.

 

Terms of the deal call for GSK to use Fluidigm's multi-layer soft lithography technology in pharmaceutical development.

 

Fluidigm said in a statement on Monday that its platform will allow GSK researchers to redesign chips very quickly-in a matter of weeks, rather than months.

 

For its part, the pharma giant is working to accelerate drug development by developing microfluidic instruments that are highly automated and can work with small sample volumes.

 

Financial details of the agreement were not disclosed.

 

Fluidigm, based in South San Francisco, Calif., develops lab-on-a-chip technology. It has invented a sandwiched rubber chip with built-in microfluidics for applications in mixing and cell sorting and mixing, and intend to adapt the technology for use in protein separation, sample preparation, and single molecule analysis.

 

The firm signed an agreement with Axon Instruments in July 2001 to develop a cell capture and microfluidics chip for drug discovery.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.